DDIT4 and breast cancer: On the other hand, DDIT4 evaluation in the SurvExpress platform showed that DDIT4 expression was related to a poor prognosis (in terms of RFS) in 3 out of 15 breast cancer datasets (Vant Veer Nature, GSE4922 and GSE19615).